Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
about
Exosomes: The Link between GPCR Activation and Metastatic Potential?Ligustrazine monomer against cerebral ischemia/reperfusion injuryMetabotropic glutamate receptors: from the workbench to the bedside.Metabotropic glutamate receptors (mGlus) and cellular transformation.Metabotropic glutamate receptors as a new therapeutic target for malignant gliomasQ's next: the diverse functions of glutamine in metabolism, cell biology and cancer.Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.Delving into somatic variation in sporadic melanoma.Molecular pathways: dysregulated glutamatergic signaling pathways in cancerThe sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas.Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: potential therapeutic application for treatment of gliomasGlutamate and the biology of gliomas.Glutamatergic signaling in cellular transformation.Oxidative stress and cancer pain.The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.BMPs as therapeutic targets and biomarkers in astrocytic glioma.Metabotropic glutamate receptors in cancer.Glutamate release from astrocyte cell-line GL261 via alterations in the intracellular ion environment.Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma.Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas.Mislocalization of the exitatory amino-acid transporters (EAATs) in human astrocytoma and non-astrocytoma cancer cells: effect of the cell confluence.Glutamate-induced glioma cell proliferation is prevented by functional expression of the glutamate transporter GLT-1.Metabotropic glutamate receptors regulate differentiation of embryonic stem cells into GABAergic neurons.Mining the glioma susceptibility genes in children from gene expression profiles and a methylation database.mGlu Receptors and Cancerous Growth.The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesisReconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma.Identification of potential therapeutic targets for gliomas by bioinformatics analysis.Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells.A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.mGlu3 receptor blockade inhibits proliferation and promotes astrocytic phenotype in glioma stem cells.Activity of Metabotropic Glutamate Receptor 4 Suppresses Proliferation and Promotes Apoptosis With Inhibition of Gli-1 in Human Glioblastoma Cells.
P2860
Q26752479-9795EA9F-6CFE-4227-A8D2-C0D1D4130B2EQ26862626-1E685B31-C6AC-4F65-B4A6-05F0FBCFD6BAQ30448778-AED7A414-77AE-41D0-BF79-1BB2FF832E34Q30487265-F49E2DDC-F134-4F37-89C0-F59FAB9D8C04Q33591900-3C1483A3-796B-402E-B9A8-10A2F206C809Q33604129-14BC1AC6-C484-4540-8BBF-1A15685EB1FBQ34749647-45990830-001D-47FC-A894-A650FAE9844DQ35190165-DFB7E2E0-E5B2-43E4-ABFC-570B624119F8Q36030770-92FF5F45-224D-4566-991D-3FBE198FF8FAQ36170150-25039EC3-8B17-4384-9B60-2EC67D1CF2F4Q36485266-7EDDD7C0-EF3C-4622-8475-4709F21B05FFQ36733346-B4641819-DB84-4320-BF2A-C63E478AC0F2Q37036910-329E921B-FA81-4C22-8E6B-115C41C3E28AQ37824652-0F489302-605D-4377-B58B-BE12C01813A0Q37978409-B69A60B5-9AD1-4B55-8D65-ECA5AD0F5B95Q38078000-7C271A01-0942-46DA-B0F3-9F8849A8273AQ38192495-3F97B245-22E2-41E4-9598-D51E3215FDDDQ38216033-9786851E-9FF7-4F06-B6FA-1EE7C701034AQ38741884-A8307DD5-2917-40DC-BCA4-2ABF804D30A0Q39085005-568CE170-7FAB-4978-82CA-5839185CAAA3Q39116562-823B7495-3106-41D5-AE61-0EAA0FC5E245Q39384950-C6C7D88A-50A0-4AD4-AD5F-C186CC7FD309Q39403123-8C98B00C-F294-42ED-B17E-4723EBF88120Q39983096-9F0851A4-C4EC-460D-BAB0-9EF824E5F713Q40028395-12C4A72C-179B-46A0-9334-2A03319B3D7BQ41619567-94E93A31-FD2C-405E-8865-548ED2F1864DQ42019418-6F2EAE57-397C-4D47-921D-D3C94250DA13Q42081827-AEF79A17-3E6A-4CA2-8503-895A5D9E2496Q43095950-EB4AA11D-3164-427B-97DF-F122B66CA51AQ47107562-F1F75AAD-A653-40B2-91D5-7BBDD60B8E45Q47169465-0262BE35-28D0-42C6-A282-C3AE3FB261ABQ49907440-2D8B6C90-F904-45E3-AA5E-E35307BD2E5DQ53068726-A9130831-68ED-42DC-A0A9-E080B685570EQ55048919-82FBA1A5-EAB3-4587-A896-E459374FC577
P2860
Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pharmacological blockade of gr ...... rowth of glioma cells in vivo.
@ast
Pharmacological blockade of gr ...... rowth of glioma cells in vivo.
@en
type
label
Pharmacological blockade of gr ...... rowth of glioma cells in vivo.
@ast
Pharmacological blockade of gr ...... rowth of glioma cells in vivo.
@en
prefLabel
Pharmacological blockade of gr ...... rowth of glioma cells in vivo.
@ast
Pharmacological blockade of gr ...... rowth of glioma cells in vivo.
@en
P2093
P2860
P50
P1433
P1476
Pharmacological blockade of gr ...... growth of glioma cells in vivo
@en
P2093
Filippo Santoro
Giulia Carpinelli
Mara D'Onofrio
Paola Casolini
P2860
P304
P356
10.1215/S1152851704000961
P577
2005-07-01T00:00:00Z